Day: January 20, 2026

Vancouver, B.C., Jan. 20, 2026 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8A) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce that Cameron Chell, the Chief Executive Officer of the Company, has been appointed Executive Chairman of the board of the directors (the “Board”), replacing Mr. Scott Larson, who will continue serving as a member of the Board. Mr. Chell has been the Chief Executive Officer of the ‎Company since ‎August ‎‎2019. “On behalf of the Board and the Company’s senior leadership team, I would like to thank Scott Larson for his hard work and dedication as the Chair of the Board over the past several years.” said Mr. Chell. About Draganfly Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8A) is the creator...

Such is Expected to Launch in the First Half of 2026, Creating New Ways to Interact with Dogecoin NEW YORK and MIAMI, Jan. 20, 2026 (GLOBE NEWSWIRE) — House of Doge Inc., the official corporate arm of the Dogecoin Foundation, along with Merger Partner Brag House Holdings Inc. (NASDAQ: TBH), are proud to announce the development of a new mobile application titled “Such”, which is expected to launch in the first half of 2026. The Such app will offer Dogecoin users a new and direct way to engage with payments and bring further real world utility to Dogecoin. The Such app will not only help users create their own wallet and purchase Dogecoin, but also offer a new way to engage with small businesses. Through the “Hustles” feature, users will be able to implement Dogecoin payments and introduce a new transaction channel for their customers. “I’ve...

Interim results indicate NS002 demonstrated significantly faster absorption and higher peak epinephrine levels compared to EpiPen® 91% of study participants achieved the 100 pg/ml plasma threshold at 5 minutes with NS002 compared to 67% with EpiPen®   NS002 was well-tolerated with no serious adverse events reported, and a pharmacodynamic response comparable to EpiPen® Full Phase 2 results expected by the end of first quarter of 2026; Pivotal study initiation planned for fourth quarter of 2026 TEL AVIV, Jan. 20, 2026 (GLOBE NEWSWIRE) — Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions, today announced positive interim results from its Phase 2 clinical...

AI-enabled, wireless solution provides anonymous insights into congestion, movement, and behavior across complex terminal environments EDMONTON, Alberta, Jan. 20, 2026 (GLOBE NEWSWIRE) — Agereh Technologies Inc. (“Agereh” or the “Company”) (TSXV: AUTO | OTCQB: CRBAF), a Canadian-based artificial intelligence and advanced technology company delivering AI-enabled platforms and sensor solutions to address critical challenges in the transportation industry, is pleased to announce the launch of HeadCounter™, a battery-powered, wireless device that delivers anonymous, real-time intelligence on passenger movement, congestion, and behavior across large, complex indoor and outdoor transportation environments. HeadCounter™ is an AI-platform to accurately count passengers, track movement patterns, and measure body temperatures...

VANCOUVER, British Columbia, Jan. 20, 2026 (GLOBE NEWSWIRE) — GoGo AI Network Inc. (CSE: GOGO) (OTC: GOGAF) (FSE: 4E9) (the “Company” or “GoGo”) is pleased to provide a corporate update on a meaningful commercial milestone achieved by Algo8, one of GoGo’s core portfolio companies. Algo8, an enterprise industrial artificial intelligence company focused on manufacturing, infrastructure, and large-scale operational systems, has commenced Phase 1 implementation of a multi-plant digital transformation initiative with a global tire manufacturer (customer name withheld for confidentiality). The engagement is designed to enhance manufacturing efficiency and improve Gross Value Added (“GVA”)—a measure of plant-level value creation—through the application of advanced AI-driven production systems. HighlightsPhase 1 deployment underway at...

New third-generation optical loss test set delivers native MMC and MPO support with fast, accurate certification of up to 24 fibersCertiFiber Max Sets a New Benchmark for High-Density Multi-Fiber Testing in Data CentersNew third-generation optical loss test set delivers native MMC and MPO support with fast, accurate certification of up to 24 fibersCertiFiber Max Sets a New Benchmark for High-Density Multi-Fiber Testing in Data CentersNew third-generation optical loss test set delivers native MMC and MPO support with fast, accurate certification of up to 24 fibersEverett, Washington, Jan. 20, 2026 (GLOBE NEWSWIRE) — Fluke Networks today announced the launch of CertiFiber™ Max, the industry’s first third-generation optical loss test set (OLTS) designed to meet the growing demands of high-density data center...

BOCA RATON, Fla., Jan. 20, 2026 (GLOBE NEWSWIRE) — LIXTE Biotechnology Holdings, Inc. (“LIXTE” or the “Company”) (Nasdaq: LIXT), a clinical-stage pharmaceutical company advancing LB-100, a first-in-class inhibitor of protein phosphatase 2A (PP2A), today announced the Company will participate at the DealFlow Discovery Conference in Atlantic City, New Jersey, January 28-29, 2026. Geordan Pursglove, LIXTE’s Chief Executive Officer, will conduct one-on-one meetings with investors during the conference. The conference will be held at The Borgata Hotel, Casino & Spa, 1 Borgata Way. To register or schedule a one-on-one meeting, please visit https://dealflowdiscoveryconference.com/registration/ About LIXTE Biotechnology Holdings, Inc. LIXTE Biotechnology Holdings, Inc. is a clinical-stage pharmaceutical company focused on new targets...

Certification affirms compliance with international cyber-resilience standards for onboard computer-based systems SINGAPORE, Jan. 20, 2026 (GLOBE NEWSWIRE) — iOThree Limited (“iO3” or the “Company”) (NASDAQ: IOTR), a pioneering provider of digital solutions for the maritime industry, announces that V.Secure, its maritime cybersecurity system with a managed Security Operations Center (SOC), has been granted IACS UR E27 Type Approval by RINA, the international classification society. This certification confirms that V.Secure meets the IACS technical cybersecurity requirements for Computer-Based Systems (CBS) installed on board ships. IACS UR E27 defines cyber-resilience requirements for onboard systems, covering access control, malicious code protection, event logging, communications integrity, recovery support...

Proposed Combined Company Will be a Cash-Generating, AI-Focused Digital Infrastructure Platform AI-Ready Data Centers, Low-Cost Power and Strategic U.S. Locations Anchor Long-Term Operating Strategy BlockchAIn 2024 Revenue of ~$22.9 Million and Net Income of ~$5.7 Million, with Infrastructure Expansion Expected to Support Up to 5x Increase in Data Center Capacity Over Time Business Combination Anticipated to Close in February or March 2026 SCOTTSDALE, AZ, Jan. 20, 2026 (GLOBE NEWSWIRE) — Signing Day Sports, Inc. (“Signing Day Sports” or the “Company”) (NYSE American: SGN), today announced its continued focus on progressing toward completion of its previously announced business combination with BlockchAIn Digital Infrastructure, Inc. (“BlockchAIn Inc.”), One Blockchain LLC (“BlockchAIn LLC”), and certain affiliates (collectively,...

Industry veteran brings decades of experience in artificial intelligence, digital transformation and large-scale technology operations to support Alignment’s next phase of growth ORANGE, Calif., Jan. 20, 2026 (GLOBE NEWSWIRE) — Alignment Health, an award-winning Medicare Advantage (MA) company, today announced the appointment of Adnan Mansour as chief digital officer, an executive leadership role that unifies the company’s technology and information functions to drive scalable growth and continued innovation. Mansour, formerly senior vice president and chief information officer at Optum Insight – the data, analytics and managed services division of UnitedHealth Group – brings decades of experience leading global IT and engineering teams and embedding artificial intelligence (AI) into complex health care systems. Effective Jan....